Teva Pharmaceutical Earnings: Why TEVA Stock Is Tanking Today
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week